Long Chain Polyunsaturated Fatty Acids in Chronic Childhood Disorders: Panacea, Promising, or Placebo

This publication has 10 references indexed in Scilit:

• Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children
  Archives of Disease in Childhood, 2003
• Plasma long‐chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria
  Developmental Medicine and Child Neurology, 2003
• Fish oil supplementation improves visual evoked potentials in children with phenylketonuria
  Neurology, 2001
• A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder
  The Journal of Pediatrics, 2001
• Long chain polyunsaturated fatty acids (LC‐PUFA) and perinatal development
  Acta Paediatrica, 2001
• Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia
  The Journal of Pediatrics, 2000
• Peroxisomal disorders
  Current Opinion in Pediatrics, 1999
• A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr ^−/− mice
  Proceedings of the National Academy of Sciences, 1999
• MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders
  Neurology, 1998
• Early breastfeeding is linked to higher intelligence quotient scores in dietary treated phenylketonuric children
  Acta Paediatrica, 1996